According to the Zhito Finance APP, Edan Instruments, Inc. (300206.SZ) announced that its stocks have experienced a cumulative closing price increase deviation of over 30% for three consecutive trading days on November 21, November 22, and November 25, indicating an abnormal fluctuation in stocks.

The announcement shows that on March 15, 2024, and November 20, the company disclosed the "Voluntary Announcement on Cooperative Development Project with Global Health Labs, Inc." and the "Voluntary Announcement on Progress of Cooperative Development Project with Global Health Labs, Inc." on the Giant Tide Information Network, respectively. The products developed under this project integrate AI-based prenatal auxiliary screening functions on handheld ultrasound devices. By using deep learning neural networks, prenatal fetal diagnostic parameters are extracted from blind scan ultrasound videos to assist in identifying early risks for pregnant women and fetuses, thereby improving the health levels of women and children in low- and middle-income countries. Currently, the algorithm model of the product has been developed, and clinical images are being collected globally to further optimize the algorithm's performance. Subsequent approval registration must be completed according to the regulations of the target sales countries before formal market sales can begin, hence no sales revenue has been generated yet. There are already similar products based on the same technology available in the market. In addition, the company has received funding from Global Health Labs, Inc. and the Bill and Melinda Gates Foundation, and the specific amounts will be determined in batches based on project goals, milestone completion conditions, and contract agreements.